Ulcerative Colitis Market - Global Outlook and Forecast 2021-2027

Code: RW00014630294
Market Monitor Global
Nov-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Ulcerative Colitis in Global, including the following market information:
Global Ulcerative Colitis Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Ulcerative Colitis market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Ulcerative Colitis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ulcerative Colitis Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Ulcerative Colitis Market Segment Percentages, By Type, 2020 (%)
Oral
Injection

China Ulcerative Colitis Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Ulcerative Colitis Market Segment Percentages, By Application, 2020 (%)
Hospital
Drugs Stores

Global Ulcerative Colitis Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Ulcerative Colitis Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Ulcerative Colitis Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Ulcerative Colitis Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Johnson & Johnson.
AbbVie
Takeda Pharmaceuticals
Roche
Warner Chilcott
Salix Pharmaceuticals/Santarus
Takeda
Ferring Pharmaceuticals
Pfizer
InDeX Pharmaceuticals

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Ulcerative Colitis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ulcerative Colitis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ulcerative Colitis Overall Market Size
2.1 Global Ulcerative Colitis Market Size: 2021 VS 2027
2.2 Global Ulcerative Colitis Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ulcerative Colitis Players in Global Market
3.2 Top Global Ulcerative Colitis Companies Ranked by Revenue
3.3 Global Ulcerative Colitis Revenue by Companies
3.4 Top 3 and Top 5 Ulcerative Colitis Companies in Global Market, by Revenue in 2020
3.5 Global Companies Ulcerative Colitis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ulcerative Colitis Players in Global Market
3.6.1 List of Global Tier 1 Ulcerative Colitis Companies
3.6.2 List of Global Tier 2 and Tier 3 Ulcerative Colitis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ulcerative Colitis Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Injection
4.2 By Type - Global Ulcerative Colitis Revenue & Forecasts
4.2.1 By Type - Global Ulcerative Colitis Revenue, 2016-2021
4.2.2 By Type - Global Ulcerative Colitis Revenue, 2022-2027
4.2.3 By Type - Global Ulcerative Colitis Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ulcerative Colitis Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Drugs Stores
5.2 By Application - Global Ulcerative Colitis Revenue & Forecasts
5.2.1 By Application - Global Ulcerative Colitis Revenue, 2016-2021
5.2.2 By Application - Global Ulcerative Colitis Revenue, 2022-2027
5.2.3 By Application - Global Ulcerative Colitis Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Ulcerative Colitis Market Size, 2021 & 2027
6.2 By Region - Global Ulcerative Colitis Revenue & Forecasts
6.2.1 By Region - Global Ulcerative Colitis Revenue, 2016-2021
6.2.2 By Region - Global Ulcerative Colitis Revenue, 2022-2027
6.2.3 By Region - Global Ulcerative Colitis Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Ulcerative Colitis Revenue, 2016-2027
6.3.2 US Ulcerative Colitis Market Size, 2016-2027
6.3.3 Canada Ulcerative Colitis Market Size, 2016-2027
6.3.4 Mexico Ulcerative Colitis Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Ulcerative Colitis Revenue, 2016-2027
6.4.2 Germany Ulcerative Colitis Market Size, 2016-2027
6.4.3 France Ulcerative Colitis Market Size, 2016-2027
6.4.4 U.K. Ulcerative Colitis Market Size, 2016-2027
6.4.5 Italy Ulcerative Colitis Market Size, 2016-2027
6.4.6 Russia Ulcerative Colitis Market Size, 2016-2027
6.4.7 Nordic Countries Ulcerative Colitis Market Size, 2016-2027
6.4.8 Benelux Ulcerative Colitis Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Ulcerative Colitis Revenue, 2016-2027
6.5.2 China Ulcerative Colitis Market Size, 2016-2027
6.5.3 Japan Ulcerative Colitis Market Size, 2016-2027
6.5.4 South Korea Ulcerative Colitis Market Size, 2016-2027
6.5.5 Southeast Asia Ulcerative Colitis Market Size, 2016-2027
6.5.6 India Ulcerative Colitis Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Ulcerative Colitis Revenue, 2016-2027
6.6.2 Brazil Ulcerative Colitis Market Size, 2016-2027
6.6.3 Argentina Ulcerative Colitis Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ulcerative Colitis Revenue, 2016-2027
6.7.2 Turkey Ulcerative Colitis Market Size, 2016-2027
6.7.3 Israel Ulcerative Colitis Market Size, 2016-2027
6.7.4 Saudi Arabia Ulcerative Colitis Market Size, 2016-2027
6.7.5 UAE Ulcerative Colitis Market Size, 2016-2027
7 Players Profiles
7.1 Johnson & Johnson.
7.1.1 Johnson & Johnson. Corporate Summary
7.1.2 Johnson & Johnson. Business Overview
7.1.3 Johnson & Johnson. Ulcerative Colitis Major Product Offerings
7.1.4 Johnson & Johnson. Ulcerative Colitis Revenue in Global (2016-2021)
7.1.5 Johnson & Johnson. Key News
7.2 AbbVie
7.2.1 AbbVie Corporate Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Ulcerative Colitis Major Product Offerings
7.2.4 AbbVie Ulcerative Colitis Revenue in Global (2016-2021)
7.2.5 AbbVie Key News
7.3 Takeda Pharmaceuticals
7.3.1 Takeda Pharmaceuticals Corporate Summary
7.3.2 Takeda Pharmaceuticals Business Overview
7.3.3 Takeda Pharmaceuticals Ulcerative Colitis Major Product Offerings
7.3.4 Takeda Pharmaceuticals Ulcerative Colitis Revenue in Global (2016-2021)
7.3.5 Takeda Pharmaceuticals Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Ulcerative Colitis Major Product Offerings
7.4.4 Roche Ulcerative Colitis Revenue in Global (2016-2021)
7.4.5 Roche Key News
7.5 Warner Chilcott
7.5.1 Warner Chilcott Corporate Summary
7.5.2 Warner Chilcott Business Overview
7.5.3 Warner Chilcott Ulcerative Colitis Major Product Offerings
7.5.4 Warner Chilcott Ulcerative Colitis Revenue in Global (2016-2021)
7.5.5 Warner Chilcott Key News
7.6 Salix Pharmaceuticals/Santarus
7.6.1 Salix Pharmaceuticals/Santarus Corporate Summary
7.6.2 Salix Pharmaceuticals/Santarus Business Overview
7.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Major Product Offerings
7.6.4 Salix Pharmaceuticals/Santarus Ulcerative Colitis Revenue in Global (2016-2021)
7.6.5 Salix Pharmaceuticals/Santarus Key News
7.7 Takeda
7.7.1 Takeda Corporate Summary
7.7.2 Takeda Business Overview
7.7.3 Takeda Ulcerative Colitis Major Product Offerings
7.4.4 Takeda Ulcerative Colitis Revenue in Global (2016-2021)
7.7.5 Takeda Key News
7.8 Ferring Pharmaceuticals
7.8.1 Ferring Pharmaceuticals Corporate Summary
7.8.2 Ferring Pharmaceuticals Business Overview
7.8.3 Ferring Pharmaceuticals Ulcerative Colitis Major Product Offerings
7.8.4 Ferring Pharmaceuticals Ulcerative Colitis Revenue in Global (2016-2021)
7.8.5 Ferring Pharmaceuticals Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Ulcerative Colitis Major Product Offerings
7.9.4 Pfizer Ulcerative Colitis Revenue in Global (2016-2021)
7.9.5 Pfizer Key News
7.10 InDeX Pharmaceuticals
7.10.1 InDeX Pharmaceuticals Corporate Summary
7.10.2 InDeX Pharmaceuticals Business Overview
7.10.3 InDeX Pharmaceuticals Ulcerative Colitis Major Product Offerings
7.10.4 InDeX Pharmaceuticals Ulcerative Colitis Revenue in Global (2016-2021)
7.10.5 InDeX Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Ulcerative Colitis Market Opportunities & Trends in Global Market
Table 2. Ulcerative Colitis Market Drivers in Global Market
Table 3. Ulcerative Colitis Market Restraints in Global Market
Table 4. Key Players of Ulcerative Colitis in Global Market
Table 5. Top Ulcerative Colitis Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Ulcerative Colitis Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Ulcerative Colitis Revenue Share by Companies, 2016-2021
Table 8. Global Companies Ulcerative Colitis Product Type
Table 9. List of Global Tier 1 Ulcerative Colitis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ulcerative Colitis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Ulcerative Colitis Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Ulcerative Colitis Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Ulcerative Colitis Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Ulcerative Colitis Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Ulcerative Colitis Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Ulcerative Colitis Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Ulcerative Colitis Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Ulcerative Colitis Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Ulcerative Colitis Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Ulcerative Colitis Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Ulcerative Colitis Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Ulcerative Colitis Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Ulcerative Colitis Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Ulcerative Colitis Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Ulcerative Colitis Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Ulcerative Colitis Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Ulcerative Colitis Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Ulcerative Colitis Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Ulcerative Colitis Revenue, (US$, Mn), 2022-2027
Table 30. Johnson & Johnson. Corporate Summary
Table 31. Johnson & Johnson. Ulcerative Colitis Product Offerings
Table 32. Johnson & Johnson. Ulcerative Colitis Revenue (US$, Mn), (2016-2021)
Table 33. AbbVie Corporate Summary
Table 34. AbbVie Ulcerative Colitis Product Offerings
Table 35. AbbVie Ulcerative Colitis Revenue (US$, Mn), (2016-2021)
Table 36. Takeda Pharmaceuticals Corporate Summary
Table 37. Takeda Pharmaceuticals Ulcerative Colitis Product Offerings
Table 38. Takeda Pharmaceuticals Ulcerative Colitis Revenue (US$, Mn), (2016-2021)
Table 39. Roche Corporate Summary
Table 40. Roche Ulcerative Colitis Product Offerings
Table 41. Roche Ulcerative Colitis Revenue (US$, Mn), (2016-2021)
Table 42. Warner Chilcott Corporate Summary
Table 43. Warner Chilcott Ulcerative Colitis Product Offerings
Table 44. Warner Chilcott Ulcerative Colitis Revenue (US$, Mn), (2016-2021)
Table 45. Salix Pharmaceuticals/Santarus Corporate Summary
Table 46. Salix Pharmaceuticals/Santarus Ulcerative Colitis Product Offerings
Table 47. Salix Pharmaceuticals/Santarus Ulcerative Colitis Revenue (US$, Mn), (2016-2021)
Table 48. Takeda Corporate Summary
Table 49. Takeda Ulcerative Colitis Product Offerings
Table 50. Takeda Ulcerative Colitis Revenue (US$, Mn), (2016-2021)
Table 51. Ferring Pharmaceuticals Corporate Summary
Table 52. Ferring Pharmaceuticals Ulcerative Colitis Product Offerings
Table 53. Ferring Pharmaceuticals Ulcerative Colitis Revenue (US$, Mn), (2016-2021)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Ulcerative Colitis Product Offerings
Table 56. Pfizer Ulcerative Colitis Revenue (US$, Mn), (2016-2021)
Table 57. InDeX Pharmaceuticals Corporate Summary
Table 58. InDeX Pharmaceuticals Ulcerative Colitis Product Offerings
Table 59. InDeX Pharmaceuticals Ulcerative Colitis Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Ulcerative Colitis Segment by Type
Figure 2. Ulcerative Colitis Segment by Application
Figure 3. Global Ulcerative Colitis Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Ulcerative Colitis Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Ulcerative Colitis Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ulcerative Colitis Revenue in 2020
Figure 8. By Type - Global Ulcerative Colitis Revenue Market Share, 2016-2027
Figure 9. By Application - Global Ulcerative Colitis Revenue Market Share, 2016-2027
Figure 10. By Region - Global Ulcerative Colitis Revenue Market Share, 2016-2027
Figure 11. By Country - North America Ulcerative Colitis Revenue Market Share, 2016-2027
Figure 12. US Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Ulcerative Colitis Revenue Market Share, 2016-2027
Figure 16. Germany Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 17. France Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Ulcerative Colitis Revenue Market Share, 2016-2027
Figure 24. China Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 28. India Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Ulcerative Colitis Revenue Market Share, 2016-2027
Figure 30. Brazil Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Ulcerative Colitis Revenue Market Share, 2016-2027
Figure 33. Turkey Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Ulcerative Colitis Revenue, (US$, Mn), 2016-2027
Figure 37. Johnson & Johnson. Ulcerative Colitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AbbVie Ulcerative Colitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Takeda Pharmaceuticals Ulcerative Colitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Roche Ulcerative Colitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Warner Chilcott Ulcerative Colitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Salix Pharmaceuticals/Santarus Ulcerative Colitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Takeda Ulcerative Colitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Ferring Pharmaceuticals Ulcerative Colitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Pfizer Ulcerative Colitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. InDeX Pharmaceuticals Ulcerative Colitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Johnson & Johnson.
AbbVie
Takeda Pharmaceuticals
Roche
Warner Chilcott
Salix Pharmaceuticals/Santarus
Takeda
Ferring Pharmaceuticals
Pfizer
InDeX Pharmaceuticals

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE